Psoriatic arthritis (PsA) risk persists throughout the psoriasis disease course and is higher in patients with severe disease, longer duration, and high-risk phenotypes such as scalp, nail, or inverse ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

A comparative analysis identifies the top IL-23 inhibitors that were least likely to be associated with the development of ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...